Insider Transactions Reported by 21 Insiders of Ventyx Biosciences, Inc.

Symbol: VTYX on Nasdaq
Location: San Diego, CA

Quick Takeaways

VTYX - Ventyx Biosciences, Inc. has 21 insiders with reported activity on this page.
Net insider value flow over the last year: -$463,300.
Recent transaction rows are available for direct filing-level review.

What Changed

Buy value: ; sell value: $463,300.
Net share flow: <span class="text-red-600">-60,020</span>.

Why This Matters

This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Official SEC Source

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Net insider flow leans to selling over the last 12 months. Net value: -$463,300.

Buys

Shares: 0

Insiders: 0

Sells

$463,300

Shares: 60,020

Insiders: 2

Net

-$463,300

Shares: -60,020

Insiders: -2

Window (months)	Sell shares	Buy $	Sell $	Net $
0-3	0	$0	$0	$0
3-6	60,020	$0	$463,300	+$463,300
6-9	0	$0	$0	$0
9-12	0	$0	$0	$0

Ventyx Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Valuation	Report Date
NSV Partners III LP	10%+ Owner	$38,381,603			Mixed	24 Jun 2024
NSV Investments I, L.P.	10%+ Owner	$35,776,685			Mixed	25 Oct 2021
Cormorant Asset Management, LP	Former 10% Owner	$2,986,881			Mixed	25 Oct 2021
Christopher W. Krueger	Chief Business Officer	$1,613,478			Mixed	02 Apr 2024
Martin Auster	Chief Financial Officer	$204,778			Mixed	02 Apr 2024
William J. Sandborn	President and Chief Medical Officer	$153,723			Mixed	31 Aug 2023
Raju Mohan	CEO AND PRESIDENT, Director	$55,904	-$365,461	-87%	Mixed	04 Mar 2026
John Nuss	Chief Scientific Officer	$21,389	-$97,840	-82%	Mixed	04 Mar 2026
Mark S. Forman	Chief Medical Officer	$0			Mixed	04 Mar 2026
Subramaniam Somu	Director	$0			Mixed	04 Mar 2026
Roy Gonzales	Senior VP, Finance	$0			Mixed	04 Mar 2026
Sheila Gujrathi	Director	$0			Mixed	04 Mar 2026
Allison Hulme	Director				Mixed	04 Mar 2026
Matthew Richard Moore	Chief Operating Officer				Mixed	04 Mar 2026
venBio Global Strategic Fund III, L.P.	Other*, 10%+ Owner				Mixed	09 Jun 2022
Jorn Drappa	Chief Medical Officer				Mixed	04 Feb 2022
Aaron Royston	Director				Mixed	09 Jun 2022
Richard Gaster	Director				Mixed	09 Jun 2022
William Richard White	Director				Mixed	04 Mar 2026
Onaiza Cadoret-Manier	Director				Mixed	04 Mar 2026
Jigar Choksey	Director				Mixed	09 Jun 2022

Top shareholders of Ventyx Biosciences, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
GLAZER CAPITAL, LLC	13D/G	—	6.2%	4,446,004	$61,754,996	$0	12 Feb 2026	13D/G
Affinity Asset Advisors, LLC	13F 13D/G	Company	9% from 13D/G	6,484,558	$58,555,559	—	31 Dec 2025	13F 13D/G
Raju Mohan	13D/G 3/4/5	CEO AND PRESIDENT, Director	6%	4,387,682	$39,622,524	+$48,060	07 Jan 2026	13D/G 3/4/5
MORGAN STANLEY	13F 13D/G	Company	0.3% from 13D/G	4,292,951	$38,765,348	—	31 Dec 2025	13F 13D/G
NSV Partners III LP	3/4/5 13D/G	10%+ Owner · Subramaniam Somu	5.7% from 13D/G	7,102,969	$38,381,603	—	24 Jun 2024	3/4/5 13D/G
NSV Investments I, L.P.	3/4/5 13D/G	10%+ Owner · Somasundaram Subramaniam	7.6% from 13D/G	16,892,528	$35,776,685	—	25 Oct 2021	3/4/5 13D/G
VANGUARD GROUP INC	13F 13D/G	Company · The Vanguard Group	5.3% from 13D/G	3,943,566	$35,610,400	—	31 Dec 2025	13F 13D/G
BlackRock, Inc.	13F 13D/G	Company	1.9% from 13D/G	3,142,440	$28,376,233	—	31 Dec 2025	13F 13D/G
TANG CAPITAL MANAGEMENT LLC	13F	Company	3.9%	2,814,000	$25,410,420	—	31 Dec 2025	13F
BAKER BROS. ADVISORS LP	13F	Company	3.3%	2,349,280	$21,213,998	—	31 Dec 2025	13F
BRAIDWELL LP	13F	Company	2.7%	1,920,255	$17,339,903	—	31 Dec 2025	13F
D. E. Shaw & Co., Inc.	13F	Company	2.3%	1,665,474	$15,039,230	—	31 Dec 2025	13F
MPM BioImpact LLC	13F	Company	2.3%	1,639,061	$14,800,721	—	31 Dec 2025	13F
CITADEL ADVISORS LLC	13F 13D/G	Company · Kenneth Griffin	2% from 13D/G	1,563,611	$14,119,407	—	31 Dec 2025	13F 13D/G
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	1.7%	1,203,997	$10,872,093	—	31 Dec 2025	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	1.6%	1,118,275	$10,098,023	—	31 Dec 2025	13F
Point72 Asset Management, L.P.	13D/G 13F	Company	4.5%	3,209,645	$9,981,996	-$8,351,669	30 Sep 2025	13D/G 13F
683 Capital Management, LLC	13F	Company	1.5%	1,040,000	$9,391,200	—	31 Dec 2025	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.4%	989,917	$8,938,951	—	31 Dec 2025	13F
Ikarian Capital, LLC	13F	Company	1.3%	958,704	$8,657,097	—	31 Dec 2025	13F
JANE STREET GROUP, LLC	13F	Company	1.3%	941,067	$8,497,835	—	31 Dec 2025	13F
GOLDMAN SACHS GROUP INC	13F	Company	1.2%	837,602	$7,563,546	—	31 Dec 2025	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	1.1%	773,512	$6,978,000	—	31 Dec 2025	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1%	742,544	$6,702,415	—	31 Dec 2025	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	1%	735,711	$6,643,470	—	31 Dec 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1%	722,355	$6,526,279	—	31 Dec 2025	13F
Artia Global Partners LP	13F	Company	0.98%	695,982	$6,284,717	—	31 Dec 2025	13F
TUDOR INVESTMENT CORP ET AL	13F	Company	0.82%	583,611	$5,270,007	—	31 Dec 2025	13F
STATE STREET CORP	13F	Company	0.77%	548,743	$4,955,149	—	31 Dec 2025	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.75%	538,071	$4,858,781	—	31 Dec 2025	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0.63%	452,310	$4,084,359	—	31 Dec 2025	13F
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.	13F	Company	0.6%	430,000	$3,883,000	—	31 Dec 2025	13F
Squadron Capital Management LLC	13F	Company	0.57%	410,000	$3,702,300	—	31 Dec 2025	13F
Sio Capital Management, LLC	13F 13D/G	Company	3.6% from 13D/G	387,751	$3,501,392	—	31 Dec 2025	13F 13D/G
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.54%	383,231	$3,460,576	—	31 Dec 2025	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.53%	375,000	$3,386,250	—	31 Dec 2025	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.5%	359,930	$3,250,168	—	31 Dec 2025	13F
Cormorant Asset Management, LP	3/4/5	Former 10% Owner	— class O/S missing	1,410,303	$2,986,881	—	25 Oct 2021	3/4/5
BANK OF AMERICA CORP /DE/	13F 13D/G	Company	1.4% from 13D/G	316,856	$2,861,209	—	31 Dec 2025	13F 13D/G
TCG Crossover Management, LLC	13F	Company	0.44%	316,195	$2,855,241	—	31 Dec 2025	13F
Qube Research & Technologies Ltd	13F	Company	0.38%	273,444	$2,469,199	—	31 Dec 2025	13F
MOODY ALDRICH PARTNERS LLC	13F	Company	0.37%	262,938	$2,374,330	—	31 Dec 2025	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.35%	251,994	$2,275,506	—	31 Dec 2025	13F
Opaleye Management Inc.	13F	Company	0.35%	251,932	$2,274,946	—	31 Dec 2025	13F
ING GROEP NV	13F	Company	0.33%	239,000	$2,158,170	—	31 Dec 2025	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.33%	233,600	$2,109,408	—	31 Dec 2025	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.32%	227,229	$2,051,878	—	31 Dec 2025	13F
DIADEMA PARTNERS LP	13F	Company	0.28%	200,000	$1,806,000	—	31 Dec 2025	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.25%	180,114	$1,626,429	—	31 Dec 2025	13F
Christopher W. Krueger	3/4/5	CHIEF BUSINESS OFFICER	— mixed-class rows	423,593 mixed-class rows	$1,613,478	—	02 Apr 2024	3/4/5

Recent Insider Transactions by Companies or Individuals for Ventyx Biosciences, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership
Roy Gonzales	VTYX	Common Stock	Disposed to Issuer	-100%			-5,313	0	04 Mar 2026	Direct
Roy Gonzales	VTYX	Stock Option (Right to Buy)	Disposed to Issuer	-100%			-281,700	0	04 Mar 2026	Direct
Somu Subramaniam	VTYX	Common Stock	Disposed to Issuer	-100%			-3,337,495	0	04 Mar 2026	See Footnote
Somu Subramaniam	VTYX	Stock Option (Right to Buy)	Disposed to Issuer	-100%			-130,762	0	04 Mar 2026	Direct
William Richard White	VTYX	Stock Option (Right to Buy)	Disposed to Issuer	-100%			-249,882	0	04 Mar 2026	Direct
Matthew Richard Moore	VTYX	Stock Option (Right to Buy)	Disposed to Issuer	-100%			-465,000	0	04 Mar 2026	Direct
Onaiza Cadoret-Manier	VTYX	Stock Option (Right to Buy)	Disposed to Issuer	-100%			-129,364	0	04 Mar 2026	Direct
Allison Hulme	VTYX	Stock Option (Right to Buy)	Disposed to Issuer	-100%			-129,364	0	04 Mar 2026	Direct
Sheila Gujrathi	VTYX	Common Stock	Disposed to Issuer	-100%			-130,000	0	04 Mar 2026	See Footnote
Sheila Gujrathi	VTYX	Stock Option (Right to Buy)	Disposed to Issuer	-100%			-1,131,072	0	04 Mar 2026	Direct
John Nuss	VTYX	Common Stock	Disposed to Issuer	-100%			-489,481	0	04 Mar 2026	Direct
John Nuss	VTYX	Stock Option (right to buy)	Disposed to Issuer	-100%			-1,307,604	0	04 Mar 2026	Direct
John Nuss	VTYX	Restricted Stock Units	Disposed to Issuer	-100%			-9,063	0	04 Mar 2026	Direct
Raju Mohan	VTYX	Common Stock	Disposed to Issuer	-100%			-2,372,863	0	04 Mar 2026	Direct
Raju Mohan	VTYX	Stock Option (Right to Buy)	Disposed to Issuer	-100%			-2,792,930	0	04 Mar 2026	Direct
Raju Mohan	VTYX	Restricted Stock Units	Disposed to Issuer	-100%			-23,688	0	04 Mar 2026	Direct
Mark S. Forman	VTYX	Common Stock	Disposed to Issuer	-100%			-6,000	0	04 Mar 2026	Direct
Mark S. Forman	VTYX	Stock Option (Right to Buy)	Disposed to Issuer	-100%			-435,000	0	04 Mar 2026	Direct
Somu Subramaniam	VTYX	Common Stock	Other	-17.2%			-694,718	3,337,495	27 Feb 2026	See Footnote
Raju Mohan	VTYX	Common Stock	Sale	-1.96%	$365,461	$7.72	-47,345	2,372,863	18 Dec 2025	Direct
John Nuss	VTYX	Common Stock	Sale	-2.52%	$97,840	$7.72	-12,675	489,481	18 Dec 2025	Direct
Raju Mohan	VTYX	Common Stock	Options Exercise	5.06%			116,668	2,420,208	17 Dec 2025	Direct
Raju Mohan	VTYX	Restricted Stock Units	Options Exercise	-100%			-116,668	0	17 Dec 2025	Direct
John Nuss	VTYX	Common Stock	Options Exercise	7.48%			34,930	502,156	17 Dec 2025	Direct
John Nuss	VTYX	Restricted Stock Units	Options Exercise	-100%			-34,930	0	17 Dec 2025	Direct
Mark S. Forman	VTYX	Common Stock	Award	100%			3,000	6,000	17 Nov 2025	Direct
Roy Gonzales	VTYX	Common Stock	Award	49.8%			1,767	5,313	17 Nov 2025	Direct
Onaiza Cadoret-Manier	VTYX	Stock Option (Right to Buy)	Award				40,000	40,000	05 Jun 2025	Direct
Allison Hulme	VTYX	Stock Option (Right to Buy)	Award				40,000	40,000	05 Jun 2025	Direct
Somu Subramaniam	VTYX	Stock Option (Right to Buy)	Award				40,000	40,000	05 Jun 2025	Direct
William Richard White	VTYX	Stock Option (Right to Buy)	Award				40,000	40,000	05 Jun 2025	Direct
Sheila Gujrathi	VTYX	Stock Option (Right to Buy)	Award				40,000	40,000	05 Jun 2025	Direct
Roy Gonzales	VTYX	Common Stock	Award	97.4%			1,750	3,546	15 May 2025	Direct
Mark S. Forman	VTYX	Common Stock	Award				3,000	3,000	15 May 2025	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.